Orchid Pharma Ltd: Merger Scheme Effective, Capital Clause Altered

Orchid Pharma Ltd announced that its Board of Directors has approved the effectiveness of a merger scheme, making it effective from July 10, 2026. Dhanuka Laboratories Limited has been dissolved without winding up. The authorized share capital of Orchid Pharma has increased to ₹164.51 crore. A record date of July 23, 2026, has been fixed for share issuance to Dhanuka shareholders. The share exchange ratio is 161 Orchid Pharma shares for every 5 Dhanuka Laboratories shares.